Powered by

ImmusanT CEO Leslie Williams to Present at Multiple Life Sciences Events to Share Company's Leadership Position in the Industry and Successful Growth Strategy

Nov 20, 2018 - GlobeNewswire

CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- ImmusanT, Inc., a clinical stage company leveraging its Epitope-Specific Immuno-Therapy„¢ (ESIT„¢) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies to patients with autoimmune diseases, 

announced today the company's chief executive officer, Leslie Williams, will participate as a featured speaker at two upcoming life sciences events: the BioEntrepreneur Bootcamp and Pitch Contest presented by Ma...